<DOC>
	<DOCNO>NCT01917877</DOCNO>
	<brief_summary>Due radiosensitivity lung , radiation-induced chemotherapy-induced pneumonitis pulmonary fibrosis frequent happen follow cancer therapy . It compromise cancer treatment , also influence patient 's life quality even death . specific treatment modality treatment-induced complication . Bevasizumab ( Avastin ) , VEGF inhibitor , attenuate serum high expression VEGF pulmonary permeability , maybe effective control acute pulmonary fibrosis . Patients randomize receive Bevasizumab ( 7mg/kg iv ) day one 21 , follow Dexamethasone ï¼ˆ10mg iv 1-10 , 5mg iv d11-15 , 2.5mg iv d16-20 ) Dexamethasone alone . The thoracic CT , plasma TNF-a , IL-6 , VEGF C-reactive protein access treatment , 24 hour Bevasizumab , 7 day , 4 8 week . target sample size 30 case .</brief_summary>
	<brief_title>Efficiency Study Acute Radiation-induced Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>clinical diagnose cancer treatmentinduced acute pulmonary fibrosis chronic pulmonary fibrosis infectioninduced pulmonary fibrosis active bleeding uncontrolled high blood pressure unstable systemic disease prior exposure VEGF inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Becacizumab</keyword>
	<keyword>pulmonary fibrosis</keyword>
	<keyword>irradiation</keyword>
	<keyword>chemotherapy</keyword>
</DOC>